Statements (81)
Predicate | Object |
---|---|
gptkbp:instance_of |
gptkb:Company
|
gptkbp:bfsLayer |
3
|
gptkbp:bfsParent |
gptkb:lake
|
gptkbp:acquisition |
gptkb:Raccoon_City
gptkb:hospital gptkb:Raccoon_City_incident gptkb:patent gptkb:Insurance_Company universities international markets clinical trials collaborations developing countries healthcare providers laboratories research institutions research teams biological samples research grants supply chains government contracts joint ventures biomedical research strategic alliances emerging markets manufacturing facilities market share research partnerships healthcare systems distribution networks research collaborations biotech firms medical device companies research data mergers clinical research organizations pharmaceutical distributors healthcare companies clinical trial networks diagnostic companies technology licenses pharmaceutical supply chains pharmaceutical patents Umbrella Corporation assets bioweapon research facilities |
gptkbp:ceo |
gptkb:Albert_Wesker
|
gptkbp:controversy |
ethical concerns
|
gptkbp:employees |
5000
|
gptkbp:founded |
gptkb:2000
|
gptkbp:founder |
gptkb:Albert_Wesker
|
gptkbp:headquarters |
gptkb:United_States
|
https://www.w3.org/2000/01/rdf-schema#label |
Tricell, Inc.
|
gptkbp:industry |
gptkb:drug
|
gptkbp:key_people |
gptkb:James_Marcus
gptkb:Alex_Wesker gptkb:William_Birkin |
gptkbp:legal_issue |
lawsuits
regulatory scrutiny |
gptkbp:location |
gptkb:Europe
gptkb:Asia gptkb:North_America |
gptkbp:market |
global
local |
gptkbp:notable_products |
gptkb:G-Virus
gptkb:T-Virus |
gptkbp:parent_company |
gptkb:lake
|
gptkbp:partnership |
government agencies
|
gptkbp:product_line |
antibiotics
antivirals vaccines therapeutics diagnostics |
gptkbp:research_focus |
bioweapons
|
gptkbp:revenue |
$1 billion
|
gptkbp:subsidiary |
gptkb:Tricell_Africa
|
gptkbp:sustainability_initiatives |
community engagement
environmental policies education initiatives research funding health programs |
gptkbp:website |
www.tricell.com
|